Bacterial Genetics & Drug Resistance

Bacterial genetics explains how bacteria acquire and exchange genetic information, and—most importantly for the clinic—how they become resistant to antibiotics. This topic stitches together molecular microbiology (mutation, plasmids, transposons), the three modes of horizontal gene transfer (transformation, transduction, conjugation) and the practical mechanisms of resistance (β-lactamases, efflux pumps, target alteration). For NEET PG it is a steady supplier of one-liner facts, paired-match items and clinical-resistance vignettes (MRSA, VRE, ESBL, MBL).

The bacterial genome: chromosome, plasmids and mobile elements

A typical bacterium has a single, circular, haploid, double-stranded DNA chromosome lying free in the cytoplasm (no nuclear membrane, no histones in true bacteria, no introns in coding genes). In addition, several extrachromosomal and mobile elements carry the genes most relevant to resistance.

Genetic element	Key features	Clinical/exam relevance
Chromosome	Circular dsDNA, essential genes, replicates from oriC	Point mutations → resistance (e.g. rifampicin, fluoroquinolones)
Plasmid	Extrachromosomal, circular, self-replicating (replicon), dispensable	Carry R factors (resistance), virulence, toxin genes
Transposon (Tn)	"Jumping genes"; move within/between DNA; cannot self-replicate	Spread resistance between plasmid and chromosome
Insertion sequence (IS)	Smallest transposon; carries only transposase	Flanks transposons; causes insertional mutations
Integron	Captures gene cassettes via integrase + attI site	Assembles multiple resistance cassettes in series
Bacteriophage / prophage	Viral DNA; lysogenic phage integrates as prophage	Mediates transduction; lysogenic conversion (toxins)

High-yield: Plasmids that carry antibiotic-resistance genes are called R factors (resistance plasmids). They classically have two components—the RTF (resistance transfer factor), which encodes conjugation machinery, and the r-determinant, which carries the actual resistance genes.

Plasmid concepts worth memorising:

• Episome = a plasmid that can integrate into the chromosome (e.g. F factor).
• Incompatibility = two plasmids of the same Inc group cannot coexist stably in one cell.
• Copy number = stringent (few copies, e.g. F) vs relaxed (many copies).
• Conjugative plasmids carry tra genes (e.g. F factor); non-conjugative plasmids can be mobilised by a helper conjugative plasmid.

Lysogenic (phage) conversion is a special, exam-favourite phenomenon where a prophage gives the bacterium a new trait. Classic examples:

• Diphtheria toxin (β-prophage in Corynebacterium diphtheriae)
• Erythrogenic/pyrogenic toxin of Streptococcus pyogenes (scarlet fever)
• Cholera toxin (CTXφ phage in Vibrio cholerae)
• Botulinum toxin (types C and D)
• Shiga toxin of E. coli O157:H7 (Shiga toxin 2)

Mutation: the vertical route to variation

Spontaneous mutations occur at a low rate (~10⁻⁶ to 10⁻¹⁰ per gene per division) and are independent of antibiotic exposure—the drug merely selects the pre-existing resistant mutant (Luria–Delbrück fluctuation experiment demonstrated this). Mutation types: point (substitution), frameshift (insertion/deletion), and large deletions. Resistance arising by chromosomal mutation is typically a single-step, high-level event for some drugs (e.g. rifampicin, streptomycin) and multi-step for others (e.g. penicillins).

High-yield: Chromosomal mutation in rpoB (RNA polymerase β-subunit) → rifampicin resistance; mutation in gyrA/parC → fluoroquinolone resistance; mutation in katG/inhA → isoniazid resistance.

Horizontal gene transfer: the three mechanisms

This is the single most testable subtopic. All three move DNA between bacteria, but the vehicle differs.

Feature	Transformation	Transduction	Conjugation
Vehicle of DNA	Naked free DNA from environment	Bacteriophage	Cell-to-cell via pilus
Cell–cell contact	No	No	Yes (sex pilus)
DNase sensitive?	Yes (destroyed by DNase)	No (DNA protected in phage)	No
Discoverer	Griffith (1928); Avery, MacLeod, McCarty (1944)	Zinder & Lederberg (1952)	Lederberg & Tatum (1946)
Classic organism	Streptococcus pneumoniae, Haemophilus, Neisseria	Salmonella, E. coli (phage λ, P1, P22)	E. coli (F factor)
Amount of DNA	Small fragments	One phage-head worth	Can transfer entire plasmid/chromosome

Transformation

Uptake of naked DNA released by a lysed donor by a competent recipient. Competence is a physiological state (natural in Pneumococcus, Neisseria, Haemophilus, Bacillus; induced artificially by CaCl₂ + heat shock or electroporation in the lab). Griffith's 1928 experiment with rough (R) and smooth (S) pneumococci first demonstrated the "transforming principle," later proven to be DNA by Avery, MacLeod and McCarty in 1944.

High-yield: Because transformation uses naked DNA, it is the only transfer method abolished by adding DNase to the medium—a recurring single-best-answer discriminator.

Transduction

Transfer of bacterial DNA from donor to recipient via a bacteriophage. Two types:

1. Generalised transduction — during the lytic cycle, fragments of host DNA are mistakenly packaged into a phage head; any gene can be transferred. Phage P22 in Salmonella is the classic.
2. Specialised (restricted) transduction — a lysogenic prophage excises imprecisely and carries only the adjacent chromosomal genes; only specific genes transferred. Phage λ in E. coli (transfers gal and bio genes) is the classic.

Flow: phage infects donor → host DNA fragment packaged → phage lyses donor → infects recipient → DNA recombines into recipient genome. → New trait acquired.

Conjugation

Direct, contact-dependent transfer of DNA through a sex (conjugation) pilus, requiring a conjugative plasmid (the F factor in E. coli).

• F⁺ × F⁻: only the F plasmid is transferred; recipient becomes F⁺. Chromosome usually not transferred.
• Hfr (High frequency recombination): F factor has integrated into the chromosome; transfers chromosomal genes in a time-dependent order (basis of interrupted mating gene mapping). The F factor is transferred last (and usually incompletely), so the recipient stays F⁻.
• F′ (F prime): F factor excises from an Hfr chromosome carrying a few chromosomal genes; transfer of these genes is called sexduction.

High-yield: Conjugation is the major route for spread of multidrug resistance (R plasmids) among Gram-negative enteric bacteria. The pilus is encoded by tra genes.

Mechanisms of antibiotic resistance

Resistance may be intrinsic (natural; e.g. Pseudomonas resistant to many agents, anaerobes to aminoglycosides, Gram-negatives to vancomycin which cannot cross the outer membrane) or acquired (mutation or horizontal transfer). The biochemical mechanisms are best grouped under four headings.

Mechanism	How it works	Classic examples
1. Enzymatic inactivation	Drug-destroying/modifying enzyme	β-lactamases (penicillinase, ESBL, AmpC, carbapenemase); aminoglycoside-modifying enzymes; chloramphenicol acetyltransferase
2. Target modification	Altered drug-binding site	PBP2a (MRSA); altered D-Ala-D-Lac (VRE); ribosomal methylation (erm/MLSb); mutated DNA gyrase, rpoB
3. Decreased uptake / efflux	Reduced entry or active pump-out	Porin loss (carbapenem resistance in Gram-negatives); efflux pumps (tetracyclines, fluoroquinolones, Pseudomonas MexAB)
4. Metabolic bypass / overproduction	Alternate pathway or excess target	Sulfonamide/trimethoprim resistance via altered DHPS/DHFR; auxotroph bypass

Mnemonic for the four mechanisms — "TIDE": Target alteration, Inactivating enzymes, Decreased permeability (porins), Efflux pumps.

β-lactamases: the dominant resistance enzymes

β-lactamases hydrolyse the β-lactam ring. They are the commonest resistance mechanism in Gram-negative bacteria.

• Penicillinase — narrow spectrum; classic Staphylococcus aureus enzyme (encoded by blaZ); overcome by methicillin/cloxacillin or β-lactamase inhibitors.
• ESBL (Extended-Spectrum β-Lactamases) — hydrolyse third-generation cephalosporins and monobactams (aztreonam); inhibited by clavulanate; do not hydrolyse carbapenems or cephamycins. Common types: CTX-M, TEM, SHV. Seen in E. coli, Klebsiella.
• AmpC β-lactamases — chromosomal/inducible; hydrolyse cephamycins (cefoxitin); NOT inhibited by clavulanate; found in Enterobacter, Citrobacter, Serratia, Pseudomonas (mnemonic "ESCaPM/SPACE" organisms).
• Carbapenemases (MBLs and others) — hydrolyse carbapenems. Metallo-β-lactamases (NDM-1, VIM, IMP) require zinc and are inhibited by EDTA (not by clavulanate); KPC is a serine carbapenemase.

High-yield: NDM-1 (New Delhi Metallo-β-lactamase-1) is a zinc-dependent metallo-β-lactamase first described from India; it confers resistance to virtually all β-lactams except aztreonam (which, however, is often still inactivated by co-existing ESBLs). It is not inhibited by clavulanic acid.

MRSA — the prototype target-modification organism

Methicillin-resistant Staphylococcus aureus resistance is not due to a β-lactamase. It results from acquisition of the mecA gene (carried on the SCCmec mobile element), which encodes an altered penicillin-binding protein PBP2a with low affinity for all β-lactams (so MRSA is resistant to all penicillins, cephalosporins and carbapenems—except the newer anti-MRSA cephalosporins ceftaroline/ceftobiprole).

Detection flow: screen with cefoxitin disc (better inducer of mecA than oxacillin) → confirm with mecA PCR or PBP2a latex agglutination. → Treat with vancomycin (or linezolid/daptomycin).

High-yield: Cefoxitin disc diffusion is the preferred phenotypic screening test for MRSA; the genotypic gold standard is detection of the mecA gene by PCR.

VRE and the D-Ala-D-Lac switch

Vancomycin binds the terminal D-Ala-D-Ala of the peptidoglycan precursor. Enterococcus acquiring the vanA (or vanB) operon replaces the terminus with D-Ala-D-Lactate, reducing vancomycin binding ~1000-fold. vanA confers high-level resistance to both vancomycin and teicoplanin (inducible, plasmid/Tn1546-borne); vanB confers variable vancomycin resistance but remains teicoplanin-susceptible.

High-yield: VRSA (vancomycin-resistant S. aureus) arises when S. aureus acquires the vanA operon from VRE by conjugation—a textbook example of inter-species horizontal transfer with major public-health consequence.

Investigation: detecting resistance in the lab

• Disc diffusion (Kirby–Bauer): zone of inhibition interpreted per CLSI breakpoints as S/I/R.
• MIC determination: broth dilution or E-test gives minimum inhibitory concentration—the quantitative gold standard.
• D-test: detects inducible clindamycin resistance (inducible MLSb). A flattening of the clindamycin zone adjacent to the erythromycin disc (a "D" shape) = positive → report clindamycin as resistant.
• Double-disc synergy / combination disc: ESBL confirmation—a ≥5 mm increase in zone of cephalosporin with clavulanate vs without.
• Modified Hodge test / mCIM: screens for carbapenemase production; EDTA-based tests distinguish metallo-β-lactamases.
• Molecular: PCR for mecA, vanA/vanB, blaNDM, blaKPC, GeneXpert MTB/RIF for rpoB.

Management principles & drugs of choice

Resistant pathogen	First-line / drug of choice
MRSA (serious infection)	Vancomycin (alt: linezolid, daptomycin, ceftaroline)
VRE	Linezolid or daptomycin (vanA: avoid both glycopeptides)
ESBL producers	Carbapenems (meropenem/imipenem)
Carbapenem-resistant / NDM	Colistin, ceftazidime-avibactam ± aztreonam, cefiderocol
C. difficile (post-antibiotic colitis)	Oral vancomycin or fidaxomicin

β-lactamase inhibitors (clavulanic acid, sulbactam, tazobactam, avibactam) are "suicide inhibitors" combined with β-lactams to restore activity—but note avibactam (a non-β-lactam inhibitor) also covers KPC/AmpC, while none of the classic inhibitors touch metallo-β-lactamases.

Complications & public-health angle

• Antimicrobial stewardship and infection control (hand hygiene, contact precautions, surveillance cultures) limit nosocomial spread of MRSA/VRE/CRE.
• Selective pressure from antibiotic overuse (including agricultural use) drives resistance evolution.
• Horizontal transfer allows rapid inter-species and inter-genus dissemination—conjugative R-plasmids are the chief culprit.
• WHO priority-pathogen list flags carbapenem-resistant Acinetobacter, Pseudomonas and Enterobacteriaceae (CRE) as critical.

Key differentials / commonly confused pairs

• Generalised vs specialised transduction — random any gene (lytic, P22) vs specific adjacent genes (lysogenic, λ).
• Transformation vs transfection — uptake of bacterial DNA vs uptake of viral DNA into a bacterium.
• ESBL vs AmpC — both Gram-negative; ESBL inhibited by clavulanate and spares cephamycins, AmpC resists clavulanate and hydrolyses cephamycins.
• MRSA (target change, mecA/PBP2a) vs penicillinase-producing S. aureus (enzyme, blaZ) — different mechanisms entirely.
• vanA vs vanB — vanA resists both vancomycin + teicoplanin; vanB usually teicoplanin-susceptible.

Recently asked / exam angle

• The mechanism abolished by DNase in the medium = transformation (recurring single-best-answer).
• Cefoxitin disc is the screening test for MRSA; mecA/PBP2a is the molecular basis.
• NDM-1 = metallo-β-lactamase, zinc-dependent, inhibited by EDTA, not clavulanate; spares aztreonam in vitro.
• Lysogenic phage conversion examples (diphtheria, cholera, botulinum, Shiga, erythrogenic toxin) are repeatedly matched.
• Hfr transfers chromosomal genes in time-dependent order; F factor transferred last → recipient remains F⁻.
• D-test detects inducible clindamycin resistance (MLSb).
• R factor = RTF + r-determinant; conjugation spreads multidrug resistance.
• vanA operon transfer from VRE → S. aureus produces VRSA.
• Luria–Delbrück / fluctuation test → mutations arise before (independent of) antibiotic exposure.

Rapid revision

1. Bacterial chromosome = single, circular, haploid dsDNA; no histones, no introns.
2. R factor = RTF (transfer) + r-determinant (resistance genes).
3. Transformation = naked DNA, DNase-sensitive; Griffith → Avery/MacLeod/McCarty proved DNA is the transforming principle.
4. Generalised transduction = lytic, any gene (P22); specialised = lysogenic, adjacent genes (λ).
5. Conjugation needs sex pilus (tra genes); Hfr transfers chromosome, F factor last.
6. Four resistance mechanisms — TIDE: Target, Inactivating enzymes, Decreased permeability, Efflux.
7. MRSA = mecA gene → PBP2a (low β-lactam affinity); screen with cefoxitin disc; treat with vancomycin.
8. ESBL inhibited by clavulanate; AmpC is not (ESCaPM/SPACE organisms); carbapenems are DOC for ESBL.
9. NDM-1 / metallo-β-lactamase = Zn-dependent, EDTA-inhibited, hydrolyses carbapenems, not inhibited by clavulanate.
10. VRE = vanA → D-Ala-D-Lactate switch; vanA resists vancomycin and teicoplanin.
11. D-test = inducible clindamycin (MLSb) resistance; E-test/MIC = quantitative gold standard.
12. Lysogenic conversion toxins: diphtheria, cholera, botulinum (C/D), Shiga, streptococcal erythrogenic.